Canada, Moderna and RSV
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...
Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...
The Wyandotte woman had worked at Blue Cross for 32 years and was denied a religious accommodation to the insurer's vaccine ...
The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...
The Associated Press on MSN2d
Why You Should Get Your Vaccines Before the Holiday RushHealth professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...
Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...
Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related to its ...
2d
Moderna Inc (MRNA) reports $1.9 billion in revenue and outlines future growth strategies despite competitive pressures and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback